United Therapeutics UTHR
NASDAQ UTHR
$541.70 -29.68 (-5.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

United Therapeutics (UTHR) Depreciation & Amortization (CF) (2009 - 2026)

Updated

United Therapeutics' Depreciation & Amortization (CF) was $24.2 million in Q2 2026, up 14.7% from $21.1 million a year earlier and up 7.1% from the prior quarter.

Analysis

United Therapeutics (UTHR) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, United Therapeutics' Depreciation & Amortization (CF) was $91.5 million through Jun 30, 2026, up 14.8% year-over-year; for FY2025, it came in at $85.6 million, up 18.1% from FY2024.

  • Depreciation & Amortization (CF) has now increased for four consecutive years, with a five-year compound annual growth rate of 11.4% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $72.5 million in FY2024 (+36.3%), $53.2 million in FY2023 (+3.7%), $51.3 million in FY2022 (+2.8%) and $49.9 million in FY2021 (unchanged).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2009.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for 17 straight quarters, with growth averaging 23.9% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q2 2024 (growth of 45.0%); the worst was Q4 2021 (a decline of 3.8%).
  • Per Business Quant data, UTHR's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $22.6 million (Q1 2026), $22.8 million (Q4 2025) and $21.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 United Therapeutics 23.13 Bn 12.62 Bn 683.80 Mn 24.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.20 Mn
Mar 31, 2026 22.60 Mn
Dec 31, 2025 22.80 Mn
Sep 30, 2025 21.90 Mn
Jun 30, 2025 21.10 Mn
Mar 31, 2025 19.80 Mn
Dec 31, 2024 19.70 Mn
Sep 30, 2024 19.10 Mn
Jun 30, 2024 18.70 Mn
Mar 31, 2024 15.00 Mn
Dec 31, 2023 13.70 Mn
Sep 30, 2023 13.30 Mn
Jun 30, 2023 12.90 Mn
Mar 31, 2023 13.30 Mn
Dec 31, 2022 13.20 Mn
Sep 30, 2022 12.90 Mn
Jun 30, 2022 12.70 Mn
Mar 31, 2022 12.50 Mn
Dec 31, 2021 12.60 Mn
Sep 30, 2021 12.40 Mn
API Access

United Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=UTHR&period=max&api_key=YOUR_API_KEY